REFERENCES
- Fruehauf JP, Bosanquet AG. In vitro determination of drug response: a discussion of clinical applications. In: Cancer: Principles and Practices of Oncology, In: VT De Vita Jr., S Hellman, and SA Rosenberg ( eds.), Philadelphia: JB Lippincott Co, 1993: 1-16.
- Morin GB. The human telomerase terminal transferase enzyme is a ribonudeoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521–529.
- Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995; 87: 884–894.
- Kim NW, Piatyszek MA, Prowse KR et al. Specific asso-ciation of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015.
- Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794–3795.
- Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996; 8: 66–71.
- Shay JW. Aging and cancer: are telomeres and telom-erase the connection? Mol Med Today 1995; 1: 378–384.
- Stevens MFG, Hickman JA, Langdon SP et al. Antitumor activity and pharmacokinetics in mice of 8-car-bamoy1-3 -methyl-imidazo [5, 1-d]-1,2,3, 5 -tetrazin-4 (3H)- one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Cancer Res 1987; 47: 5846-5852.
- Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Meth 1989; 119: 203–210.
- Piatyszek MA, Kim NW, Weinrich SL et al. Detection of telomerase activity in human cells and tumors by a telom-eric repeat amplification protocol (TRAP). Meth Cell Sci 1995; 17: 1–15.
- Tentori L, Graziani G, Gilberti S et al. Triazene com-pounds induce apoptosis in 06-alkylguanine-DNA-alkyltrans-ferase deficient leukemia cell lines. Leukemia 1995; 9: 1888–1895.
- Sevin BU, Perras JP, Averette HE, Donato DM, Penalver M. Chemosensitivity testing in ovarian cancer. Cancer 1993; 71: 1613–1620.